About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | New Daily Persistent Headache Biomarkers Study

New Daily Persistent Headache Biomarkers Study

NCT04260087·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Albert Einstein College of Medicine

With

Migraine Research Foundation
Eli Lilly and Company

Age

18–75

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

to add

You may not be if

to add

The record

StatusTerminated

PhaseNo phase

Taking part8

StartedMay 2018

UpdatedMar 3, 2022

Conditions

New Daily Persistent Headache New Daily Persistent Headache (NDPH)

Where1

Montefiore Headache Center
The Bronx, New York, United States